Skip to main content

Hoffman Michael B

In the past year, 7 open-market purchase filings worth $4.10M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$4.10M
7 filings
Sold
–
0 filings
Net
+$4.10M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Hoffman Michael B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TDAC Translational Development Acquisition Corp.

Chairman and CEO1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 29, 2026 (view filing)May 272 daysHoffman Michael BChairman and CEOPPurchaseClass A ordinary shares+53.4K$0.79+$42.2K–53.4K afterDerivative

ANVS Annovis Bio, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 21, 2026 (view filing)May 201 dayHoffman Michael BDirectorPPurchase+76.3K$1.87+$142.8K+2.3%3.36M after3 lots
Apr 3, 2026 (view filing)Apr 21 dayHoffman Michael BDirectorPPurchase+713.8K$2.10+$1.50M+27.7%3.29M after
Dec 8, 2025 (view filing)Dec 8Same dayHoffman Michael BDirectorPPurchase+45.0K$4.31+$193.8K+1.8%2.57M after2 lots
Nov 25, 2025 (view filing)Nov 241 dayHoffman Michael BDirectorPPurchase+39.2K$4.08+$159.9K+1.6%2.53M afterAmended4 lots
Nov 21, 2025 (view filing)Nov 21Same dayHoffman Michael BDirectorPPurchase+20.0K$3.50+$69.9K+0.8%2.49M after2 lots
Nov 18, 2025 (view filing)Nov 144 daysHoffman Michael BDirectorPPurchase+15.0K$2.11+$31.6K+0.6%2.47M after
Nov 12, 2025 (view filing)Oct 2815 daysLateHoffman Michael BDirectorPPurchase+975.6K$2.05+$2.00M+65.9%2.46M after